BioAge Labs, Inc. (BIOA)
5.96
+0.16
(+2.76%)
USD |
NASDAQ |
Nov 03, 16:00
5.96
0.00 (0.00%)
After-Hours: 17:51
BioAge Labs Cash and Short Term Investments (Quarterly) : 318.74M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 318.74M |
| March 31, 2026 | 383.19M |
| December 31, 2025 | 281.10M |
| September 30, 2025 | 285.78M |
| June 30, 2025 | 297.30M |
| March 31, 2025 | 320.52M |
| Date | Value |
|---|---|
| December 31, 2024 | 354.35M |
| September 30, 2024 | 334.47M |
| June 30, 2024 | 159.08M |
| March 31, 2024 | 177.30M |
| December 31, 2023 | 24.96M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Neumora Therapeutics, Inc. | 116.83M |
| Alumis, Inc. | 502.29M |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Corcept Therapeutics, Inc. | 308.20M |
| Veru, Inc. | 25.79M |